BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2211110)

  • 1. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
    Wachholz BW
    Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
    Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
    JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report.
    Rallison ML; Lotz TM; Bishop M; Divine W; Haywood K; Lyon JL; Stevens W
    Health Phys; 1990 Nov; 59(5):739-46. PubMed ID: 2211127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
    Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
    Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perspective on public concerns about exposure to fallout from the production and testing of nuclear weapons.
    Hoffman FO; Apostoaei AI; Thomas BA
    Health Phys; 2002 May; 82(5):736-48. PubMed ID: 12003022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study.
    Simon SL; Lloyd RD; Till JE; Hawthorne HA; Gren DC; Rallison ML; Stevens W
    Health Phys; 1990 Nov; 59(5):669-91. PubMed ID: 2211123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
    Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
    Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood leukemia and fallout from the Nevada nuclear tests.
    Land CE; McKay FW; Machado SG
    Science; 1984 Jan; 223(4632):139-44. PubMed ID: 6691139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests.
    Hundahl SA
    CA Cancer J Clin; 1998; 48(5):285-98. PubMed ID: 9742895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests.
    Gilbert ES; Tarone R; Bouville A; Ron E
    J Natl Cancer Inst; 1998 Nov; 90(21):1654-60. PubMed ID: 9811315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual external exposures from Nevada Test Site fallout for Utah leukemia cases and controls.
    Lloyd RD; Gren DC; Simon SL; Wrenn ME; Hawthorne HA; Lotz TM; Stevens W; Till JE
    Health Phys; 1990 Nov; 59(5):723-37. PubMed ID: 2211126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models of radioiodine transport to populations within the continental U.S.
    Bouville A; Dreicer M; Beck HL; Hoecker WH; Wachholz BW
    Health Phys; 1990 Nov; 59(5):659-68. PubMed ID: 2145245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Thyroid cancer rates and (131)I doses from Nevada atmospheric nuclear bomb tests.
    Archer VE
    J Natl Cancer Inst; 1999 Aug; 91(16):1423-5. PubMed ID: 10451455
    [No Abstract]   [Full Text] [Related]  

  • 14. The Utah Leukemia Case-Control Study: dosimetry methodology and results.
    Simon SL; Till JE; Lloyd RD; Kerber RL; Thomas DC; Preston-Martin S; Lyon JL; Stevens W
    Health Phys; 1995 Apr; 68(4):460-71. PubMed ID: 7883558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of exposure rates and fallout arrival times near the Nevada Test Site.
    Thompson CB
    Health Phys; 1990 Nov; 59(5):555-63. PubMed ID: 2211115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of doses from global fallout.
    Bouville A; Simon SL; Miller CW; Beck HL; Anspaugh LR; Bennett BG
    Health Phys; 2002 May; 82(5):690-705. PubMed ID: 12003019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer risk in the population around the Nevada Test Site.
    Zeighami EA; Morris MD
    Health Phys; 1986 Jan; 50(1):19-32. PubMed ID: 3943971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation exposures in Utah from Nevada Nuclear Tests.
    Beck HL; Krey PW
    Science; 1983 Apr; 220(4592):18-24. PubMed ID: 6828876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of fallout in the continental U.S. from Nevada weapons testing based on gummed-film monitoring data.
    Beck HL; Helfer IK; Bouville A; Dreicer M
    Health Phys; 1990 Nov; 59(5):565-76. PubMed ID: 2211116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the Department of Energy's Off-Site Radiation Exposure Review Project (ORERP).
    Church BW; Wheeler DL; Campbell CM; Nutley RV; Anspaugh LR
    Health Phys; 1990 Nov; 59(5):503-10. PubMed ID: 2211109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.